The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?
about
Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritisRate of Proven Rheumatic Diseases in a Large Collective of Referrals to an Outpatient Rheumatology Clinic Under Routine Conditions.Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation.Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker.The optimal combination therapy for the treatment of early rheumatoid arthritis.Achievement of NICE quality standards for patients with new presentation of inflammatory arthritis: observations from the National Clinical Audit for Rheumatoid and Early Inflammatory Arthritis.Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial.A general practice perspective on early rheumatoid arthritis management: A qualitative study from Flanders.Symptom Recognition and Perceived Urgency of Help-Seeking for Rheumatoid Arthritis and Other Diseases in the General Public: A Mixed Method Approach.Plasmapheresis therapy in combination with TNF-α inhibitor and DMARDs: A multitarget method for the treatment of rheumatoid arthritis.Synovial cell metabolism and chronic inflammation in rheumatoid arthritis.Toward cellular biomarkers for rheumatoid arthritis.
P2860
Q37133755-B40A882E-0056-4E42-9BF9-26D482B07A72Q37305945-4CA988BF-08DB-4D55-A765-A0F6A1E242FCQ37604540-B6EDCCF8-2FA6-4E1E-9295-B8397BF1A480Q37621002-3FECA01F-E2DA-4F14-B1AC-58DBEE3001E7Q38522457-1A84DA54-2A80-4B6C-85E3-BB055316792EQ38970157-822E742B-6C10-4B4F-B301-73D956F68EEBQ39888893-CB5E3938-7D73-4019-8186-5319FD5E3163Q40338512-AF0744EF-45BE-4A1D-84BC-D591F9AD173BQ42592025-DDD5F008-5022-408A-A4B3-1C4AC5890500Q51422302-19FDDB1F-9B96-4D3B-99CD-48E24DA6C8B5Q51759451-2C784FA5-6C2D-44DE-AF9C-8343B5471765Q51793671-D86E2ADD-F240-4B86-BE64-3B195E617B05
P2860
The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?
@en
The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?
@nl
type
label
The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?
@en
The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?
@nl
prefLabel
The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?
@en
The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?
@nl
P2860
P1476
The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?
@en
P2093
Andrew Filer
Karim Raza
P2860
P304
P356
10.1136/ANNRHEUMDIS-2014-206993
P407
P577
2015-03-10T00:00:00Z